In the liver, KCs are well-known sources of IL-1β and IL-18 during NAFLD (49, 50), and it has been shown that cholesterol treatment induces IL-1β and IL-18 production in both KCs and monocyte derived macrophages in a dose dependent manner (51). Here, TBCE is linked to metabolic dysfunction-associated steatotic liver disease.